During most of 2020, the entire world has been submerged in a health crisis due to the ongoing COVID-19 pandemic. This unprecedented situation could be a turning point in history, especially to ideally reimagine the future of hospital health. Patient needs are becoming more complex and, as the pressure on healthcare providers continues to escalate, it is clear that regenerative medicine and cell therapies promise to transform healthcare, pharma, and biotech industries by improving patient outcomes and enabling long-term economic savings. Nonetheless, how we plan to get there is still not entirely clear.
While conventional 3D printing technologies are actually applied for biological or biomedical applications, true 3D bioprinting involving direct printing of cells and other biological substances for tissue reconstruction is still in its infancy. Experts are divided as to how far we are from lab-grown organs, and moving the technology from bench to bedside could take years. To bridge this gap, the founders of Swiss biotech startup mimiX Biotherapeutics (mimiX) announced the launch of an entirely new technology that could produce multi-cellular functional tissue constructs, quickly and affordably, through sound waves.
mimiXs first acoustic bioprinter, called cymatiX, stands to transform biofabrication, say the company co-founders. They believe it will enable the field of biofabrication to overcome some major limitations of conventional bioprinting methods and direct us toward the creation of physiologically relevant in vitro models and engineered tissue constructs. The gentle, fast, and user-friendly laboratory instrument relies on the companys patented Sound Induced Morphogenesis (SIM) bioprocessing technology.
The mimiX team with the first prototype of the 3D SIM patterning instrument (From left to right: Roman Amrein, Nicola Di Marzio, Marc Thurner, and Tiziano Serra). Image courtesy of AO Foundation
The 3D-SIM technology behind mimiX biotherapeutics is nearly a decade old. It was developed by Dr. Tiziano Serra, a Research Scientist at the AO Research Institute in Davos, Switzerland, and co-founder of mimiX, with the objective of creating well-defined biological patterns that self-assemble into functional tissues using sound waves. In the past, Serra has poetically defined this process as orchestrating biology, and today SIM technology offers a unique and highly efficient strategy to fabricate dense and organized cell patterns and addresses necessities in the broad field of life sciences, finding applications in tissue engineering, regenerative medicine, and pharmaceutical research for drug discovery.
Earlier last fall, the startup published in vitro scientific results on the orchestration of vascular networks and entered an in vivo translation program driven by focused pre-clinical studies on soft tissue regeneration. Just one year after its foundation, mimiX is also disclosing a new corporate identity and its first bioprinter. mimiX CEO and Co-founder Marc Thurner revealed exclusively to 3DPrint.com that cymatiX will be available to the scientific community in 2021.
It will change biofabrication technology forever, Thurner explained. At mimiX, we work for a world where regenerative medicine is accessible to everyone, and our new emerging technology will be a paradigm shift, a completely new approach to biofabrication, leveraging researchers creativity to pattern biologicals (cells, spheroids, organoids, micrografts). The bioprinting industry was the hype of the last decade, but now, it could switch towards a new tech curve: our sound-based next-generation biotech. The new instrument will be accessible to institutes, academia, and researchers everywhere that wish to enter a new era of biofabrication hype.
As the device is still a prototype, mimiX is currently in the process of industrializing cymatiX, which will be commercialized next year. Anyone can pre-order the device and look forward to receiving it after May 2021. However, the company plans to offer cymatiX for purchase to 10 select partners in January 2021. This VIP group of researchers and scientists will be selected from a pool of interested candidates that can apply today through mimiXs website here.
mimiX biotherapeutics novel biofabrication technology exploits SIM technology to create well-defined biological architectures. Image courtesy of mimiX Biotherapeutics
Built to create biological architectures, the proprietary technology behind cymatiX will allow for clinical translation and to push the frontiers of bioprinting both in fundamental and applied research. The new SIM process represents a versatile and time-efficient strategy to create organized cell assemblies at defined spatial resolution and physiologically relevant cell density.
Quote request
Are you looking to buy a 3D printer or 3D scanner? We're here to help. Get free expert advice and quotes from trusted suppliers in your area.
Powered by Aniwaa
So, how does it work? First, biological particles, like cells, spheroids, and organoids, are dispersed in a hydrogel precursor and loaded into the SIM carrier. Then, a sound-generated vertical vibration is applied, and a pattern is created within seconds. Crosslinking of the patterned particulates within the hydrogel is carried out by using different stimuli, such as light, enzymatic, or thermal crosslinking, depending on the material. More importantly, multiple, differently patterned layers can be built sequentially.
cymatiX can create patterns, and condense matter to trigger its biological functionality, described mimiX co-founder Tiziano Serra. Instead of having dispersed cells with low density, researchers will be able to condense cells in a very fast and gentle process through the liquid movement of all the cells via a low-frequency vertical vibration applied at the bottom of the chamber. This dynamic cell condensation is one of the critical points for the regeneration of functional tissue. Moreover, we were able to predict through a simulation which kind of pattern we want to generate for a specific application, from an implantable tissue to drug screening or disease model testing.
According to the founders, this fast technique produces multicellular architectures within seconds from a large bank of sound profiles. It is cell-friendly, contactless, and mild. Controlled remotely by acoustic waves, the SIM device allows patterning of biological material into 3D constructs that develop into in vitro engineered tissues, for example, microvascular networks.
To prove the technology, Serra worked with colleagues from the Swiss National Science Foundation (SNSF) and the AO Research Institute, to prove that SIM technology can generate multiscale organized vascular networks. In a paper published in the IOPscience journal Biofabrication, the researchers developed an in vitro experimental model as a proof-of-concept to assess the feasibility of SIM for creating vascular structures.
Schematic representation of vascular network formation with SIM process. Image courtesy of Tiziano Serra/IOP Science
In the study, the researchers prove that even with a low initial density of cells, they are able to self-assembly into functional multiscale vascular networks. Furthermore, the authors conclude that this is a highly versatile method with many degrees of freedom (material, cells, patterning parameters), that can be applied to several biomedical fields, such as the development of advanced spatially-orchestrated, patient-specific micro physiological 3D models for drug screening and its implementation in bioprinting to provide automated tissue fabrication towards clinical translation.
Its all about cell condensation and patterning, these are the two secrets of life, and that is what we offer with our process, the capacity to condense and pattern. We are certain that cymatiX will offer much better performance than any other bioassembly process in the market today, suggested Thurner, who until recently was CEO of another startup that he founded, Swiss-based biotech firm regenHU. This new device is part of our vision to completely redesign regenerative medicine by increasing the patients accessibility to the point of care approach.
Read the rest here:
mimiX Biotherapeutics Unveils First Acoustic Bioprinter: Creating Life With Sound, the Next Generation of Biofabrication - 3DPrint.com
- Vascular Cell and Molecular Biology | Center for Vascular Biology | Weill Cornell ... - April 13th, 2018 [April 13th, 2018]
- APVBO-Asia Pacific Vascular Biology Organization Conference - April 18th, 2018 [April 18th, 2018]
- Vascular Biology Conferences | Vascular Surgery ... - May 5th, 2018 [May 5th, 2018]
- Vascular Discovery: From Genes to Medicine - May 7th, 2018 [May 7th, 2018]
- 2019 Vascular Cell Biology Conference GRC - May 26th, 2018 [May 26th, 2018]
- Biology 211: Taxonomy of Flowering Plants - June 7th, 2018 [June 7th, 2018]
- esm-evbo2019.org - Menu - July 27th, 2018 [July 27th, 2018]
- Vascular Biology | Pulmonary, Allergy, Sleep & Critical ... - November 16th, 2018 [November 16th, 2018]
- Lower vascular plant | biology | Britannica.com - November 18th, 2018 [November 18th, 2018]
- Vascular Biology - NAVBO - November 20th, 2018 [November 20th, 2018]
- 2019 Cerebral Vascular Biology Conference - cvent.com - November 21st, 2018 [November 21st, 2018]
- PPARs and Their Emerging Role in Vascular Biology ... - November 26th, 2018 [November 26th, 2018]
- Vascular Biology Chicago Medicine - November 30th, 2018 [November 30th, 2018]
- Vascular Biology | Society for Vascular Surgery - November 30th, 2018 [November 30th, 2018]
- Vascular Biology 2018 - NAVBO - December 19th, 2018 [December 19th, 2018]
- Vascular Biology 2019 - NAVBO - December 20th, 2018 [December 20th, 2018]
- Vascular Biology - January 22nd, 2019 [January 22nd, 2019]
- pvb2019.org Plant Vascular Biology Conference 2019 - January 31st, 2019 [January 31st, 2019]
- Plant Physiology | Basic Biology - March 12th, 2019 [March 12th, 2019]
- Awards - esm-evbo2019.org - April 23rd, 2019 [April 23rd, 2019]
- Medication and Exercise to Prevent Muscle Loss - Next Avenue - September 24th, 2019 [September 24th, 2019]
- A Snail as Fast as a Bullet, and Other Darwin-Defying Marvels - Discovery Institute - September 24th, 2019 [September 24th, 2019]
- Nature up close: Life in the Humboldt Penguin National Reserve - CBS News - September 24th, 2019 [September 24th, 2019]
- Oklahoma new hires and promotions announced - Oklahoman.com - September 24th, 2019 [September 24th, 2019]
- Quinn Capers IV, MD - TCTMD - September 24th, 2019 [September 24th, 2019]
- Cardiovascular Repair And Reconstruction Devices Market Global Industry Insights by Top Vendors, Growth, Revenue and Forecast Outlook 2019-2025 -... - September 26th, 2019 [September 26th, 2019]
- Four health projects at Boston Childrens Hospital that could help adults - The Boston Globe - September 30th, 2019 [September 30th, 2019]
- Research Officer/ Postdoctoral Researcher - The Conversation AU - October 16th, 2019 [October 16th, 2019]
- UNSW skin cancer researcher Levon Khachigian hit with string of retractions - ABC News - October 16th, 2019 [October 16th, 2019]
- Michal Wszola: We Expect to Transplant the Bioprinted Bionic Pancreas in Three to Five Years - 3DPrint.com - October 24th, 2019 [October 24th, 2019]
- 'The Blob': This mysterious 'smart' slime can solve puzzles and make decisions - CNBC - October 24th, 2019 [October 24th, 2019]
- University of Maryland and DOD collaborate to study Tick-borne Infections using 3-D models of human blood vessels - Outbreak News Today - November 19th, 2019 [November 19th, 2019]
- Submerged Vegetation Mirrors Coast's Health - Coastal Review Online - November 19th, 2019 [November 19th, 2019]
- Another health warning for e-cigarette users that has nothing to do with lung disease - MarketWatch - November 19th, 2019 [November 19th, 2019]
- E-Cigarettes Take a Dangerous Toll on Heart Health - DocWire News - November 19th, 2019 [November 19th, 2019]
- Vascular biology Department of Surgery College of ... - November 19th, 2019 [November 19th, 2019]
- US Nobel laureates tell us what they think about cancer research, moonshots, the dark side, funding, meritocracy, herd mentality, Trump, and joy - The... - November 21st, 2019 [November 21st, 2019]
- Growing Organs in the Lab: One Step Closer to Reality - BioSpace - November 21st, 2019 [November 21st, 2019]
- Inotrem Announces Enrollment of First Patient in its Phase IIb ASTONISH Trial for Nangibotide in the Treatment of Septic Shock - Business Wire - November 21st, 2019 [November 21st, 2019]
- Another Study Suggests E-cigarettes Hurt Heart Health More Than Regular Cigarettes - Science Times - November 21st, 2019 [November 21st, 2019]
- Cleveland Clinic awarded $12 million by NIH to study the link between gut microbes and heart disease - Crain's Cleveland Business - November 21st, 2019 [November 21st, 2019]
- JanOne Acquires Worldwide, Exclusive License for Promising Treatment of Peripheral Arterial Disease (PAD) - Yahoo Finance - November 27th, 2019 [November 27th, 2019]
- Germ-free lungs of newborn mice are partially protected against hyperoxia - The Mix - November 27th, 2019 [November 27th, 2019]
- Bethesda Health Physician Group Welcomes Fellowship-Trained Endocrine Surgeon Jessica L. Buicko, MD, to Its Team - The Boca Raton Tribune - November 27th, 2019 [November 27th, 2019]
- 9 Harvard researchers named AAAS Fellows Harvard - Harvard Gazette - November 27th, 2019 [November 27th, 2019]
- Top Technical Advances of 2019 - The Scientist - December 29th, 2019 [December 29th, 2019]
- Growing up Tyrannosaurus rex: Osteohistology refutes the pygmy Nanotyrannus and supports ontogenetic niche partitioning in juvenile Tyrannosaurus -... - January 2nd, 2020 [January 2nd, 2020]
- UCC currently taking applicants for 21 jobs with some incredible pay - Cork Beo - January 2nd, 2020 [January 2nd, 2020]
- Vascular Biology | Surgery Research | Michigan Medicine ... - January 2nd, 2020 [January 2nd, 2020]
- Sandy Bottom wetlands to receive protection for 'national ecological significance' - Citizen Times - January 14th, 2020 [January 14th, 2020]
- Why biotech is a boon for patients and investors - Spear's WMS - January 14th, 2020 [January 14th, 2020]
- Exonate Announces Collaboration With Janssen to Develop a New Eye Drop for the Treatment of Retinal Vascular Diseases Including Wet Age-related... - January 14th, 2020 [January 14th, 2020]
- G-protein Coupled Receptor Market Competitive Research And Precise Outlook 2019 To 2025 Dagoretti News - Dagoretti News - January 18th, 2020 [January 18th, 2020]
- Scientists revealed the oldest known scorpion on Earth - Tech Explorist - January 18th, 2020 [January 18th, 2020]
- How biology creates networks that are cheap, robust, and efficient - Penn: Office of University Communications - January 18th, 2020 [January 18th, 2020]
- Genome editing heralds new era of disease research, therapy - The Augusta Chronicle - January 18th, 2020 [January 18th, 2020]
- Research Fellow in Vascular Stem Cell Biology job with QUEENS UNIVERSITY BELFAST | 195527 - Times Higher Education (THE) - February 10th, 2020 [February 10th, 2020]
- More than skin deep: the latest innovation in 3D printing - Med-Tech Innovation - February 10th, 2020 [February 10th, 2020]
- Examining the link between menopause and heart disease risk - Medical News Bulletin - February 10th, 2020 [February 10th, 2020]
- Women Face an Increased Risk of Heart Disease With AgeRunning Can Help - runnersworld.com - February 12th, 2020 [February 12th, 2020]
- G-protein Coupled Receptor Market Competitive Research And Precise Outlook 2019 To 2025 - Galus Australis - February 15th, 2020 [February 15th, 2020]
- Valentine's Day Matters of the Heart, Biopharma-Style - BioSpace - February 15th, 2020 [February 15th, 2020]
- The Addicted Gardener: Environmental tidbits from around the world - Wicked Local Sharon - February 22nd, 2020 [February 22nd, 2020]
- UI at 150 & Beyond: 'The Quad was the best no matter what the weather' - Champaign/Urbana News-Gazette - February 22nd, 2020 [February 22nd, 2020]
- The Addicted Gardener: Environmental tidbits from around the world - Wicked Local Dedham - February 23rd, 2020 [February 23rd, 2020]
- THE ADDICTED GARDENER: Environmental tidbits from around the world - Wicked Local Wareham - March 22nd, 2020 [March 22nd, 2020]
- 'Little Foot' skull reveals how this more than 3 million year old human ancestor lived - HeritageDaily - March 22nd, 2020 [March 22nd, 2020]
- It's Not Only About Neurons - The Good Men Project - March 22nd, 2020 [March 22nd, 2020]
- Who is Sir Patrick Vallance and what is his role in government during coronavirus outbreak? - The Scottish Sun - March 22nd, 2020 [March 22nd, 2020]
- University of Washington Pathology Professor Dies of COVID-19 - The Scientist - March 22nd, 2020 [March 22nd, 2020]
- THE ADDICTED GARDENER: Environmental tidbits from around the world - Wicked Local Rochester - March 23rd, 2020 [March 23rd, 2020]
- Ancient human ancestor 'Little Foot' probably lived in trees, new research finds - WBAP News/Talk - March 23rd, 2020 [March 23rd, 2020]
- Study shows similarity in anti-VEGF injection intervals for wet AMD - Ophthalmology Times - March 25th, 2020 [March 25th, 2020]
- aTyr Pharma and its Hong Kong Subsidiary, Pangu BioPharma, Announce Government Grant to Fund Bispecific Antibody Development Platform - BioSpace - March 25th, 2020 [March 25th, 2020]
- Health researchers find solution to life-threatening side effect - Mirage News - March 25th, 2020 [March 25th, 2020]
- European Vascular Biology Organisation | Advancing human ... - March 25th, 2020 [March 25th, 2020]
- Vascular Biology Program | Boston Children's Hospital - March 25th, 2020 [March 25th, 2020]
- Vascular Biology Research Program | Johns Hopkins ... - March 25th, 2020 [March 25th, 2020]
- Anatomy of a heatwave: how Antarctica recorded a 20.75C day last month - The Conversation AU - April 1st, 2020 [April 1st, 2020]
- Who is Sir Patrick Vallance and is he speaking at todays government coronavirus press briefing? - The Sun - April 1st, 2020 [April 1st, 2020]